Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shi

Showing results (421-430 of 546) with videos related to

Pageof 55
Sort By:
Circulation. Heart Failure|February 27, 2016
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) TrialScott D Solomon, Brian Claggett, Akshay S Desai, et al.
International Journal of Andrology|September 29, 2011
A rare Y chromosome constitutional rearrangement: a partial AZFb deletion and duplication within chromosome Yp in an infertile man with severe oligoasthenoteratozoospermiaY C Shi, Y X Cui, Y C Zhou, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|February 8, 2003
[Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis]J J Chai, Menghebat, W Jiao, et al.
European Heart Journal|February 4, 2017
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HFMichael Böhm, Robin Young, Pardeep S Jhund, et al.
Nature|May 9, 2009
A large iron isotope effect in SmFeAsO(1 - x)F(x) and Ba(1 - x)K(x)Fe(2)As(2)R H Liu, T Wu, G Wu, et al.
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|September 1, 1981
[Distribution of radiothallium in organs and tumors in mice (author's transl)]Q X Sun, C P Wang, S B Qian, et al.
Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.
Journal of the American College of Cardiology|November 15, 2019
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEFMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.
Journal of Pharmaceutical Sciences|December 10, 2021
A High Energy X-ray Diffraction Study of Amorphous IndomethacinC J Benmore, S R Benmore, A D Edwards, et al.
Pageof 55

Showing results (421-430 of 546) with videos related to

Sort By:
Pageof 55
Circulation. Heart Failure|February 27, 2016
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) TrialScott D Solomon, Brian Claggett, Akshay S Desai, et al.
International Journal of Andrology|September 29, 2011
A rare Y chromosome constitutional rearrangement: a partial AZFb deletion and duplication within chromosome Yp in an infertile man with severe oligoasthenoteratozoospermiaY C Shi, Y X Cui, Y C Zhou, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|February 8, 2003
[Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis]J J Chai, Menghebat, W Jiao, et al.
European Heart Journal|February 4, 2017
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HFMichael Böhm, Robin Young, Pardeep S Jhund, et al.
Nature|May 9, 2009
A large iron isotope effect in SmFeAsO(1 - x)F(x) and Ba(1 - x)K(x)Fe(2)As(2)R H Liu, T Wu, G Wu, et al.
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|September 1, 1981
[Distribution of radiothallium in organs and tumors in mice (author's transl)]Q X Sun, C P Wang, S B Qian, et al.
Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.
Journal of the American College of Cardiology|November 15, 2019
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEFMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.
Journal of Pharmaceutical Sciences|December 10, 2021
A High Energy X-ray Diffraction Study of Amorphous IndomethacinC J Benmore, S R Benmore, A D Edwards, et al.
Pageof 55